231 related articles for article (PubMed ID: 7609991)
1. Efficacy of treatment of murine Schistosoma mansoni infections with praziquantel and oxamniquine correlates with infection intensity: role of host antibody.
Fallon PG; Hamilton JV; Doenhoff MJ
Parasitology; 1995 Jul; 111 ( Pt 1)():59-66. PubMed ID: 7609991
[TBL] [Abstract][Full Text] [Related]
2. Temporal differences in praziquantel- and oxamniquine-induced tegumental damage to adult Schistosoma mansoni: implications for drug-antibody synergy.
Fallon PG; Fookes RE; Wharton GA
Parasitology; 1996 Jan; 112 ( Pt 1)():47-58. PubMed ID: 8587801
[TBL] [Abstract][Full Text] [Related]
3. Effect of praziquantel and oxamniquine treatment on human isotype responses to Schistosoma mansoni: elevated IgE to adult worm.
Webster M; Fallon PG; Fulford AJ; Butterworth AE; Ouma JH; Kimani G; Dunne DW
Parasite Immunol; 1997 Jul; 19(7):333-5. PubMed ID: 9278946
[TBL] [Abstract][Full Text] [Related]
4. Scanning electron microscopy of the tegumental surface of in vivo treated Schistosoma mansoni (Saudi Arabian geographical strain) with oxamniquine and praziquantel.
Shalaby IM; Banaja AA; Ghandour AM
J Egypt Soc Parasitol; 1991 Dec; 21(3):797-810. PubMed ID: 1765693
[TBL] [Abstract][Full Text] [Related]
5. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.
Fallon PG; Doenhoff MJ
Am J Trop Med Hyg; 1994 Jul; 51(1):83-8. PubMed ID: 8059919
[TBL] [Abstract][Full Text] [Related]
6. Active immunization of mice with Schistosoma mansoni worm membrane antigens enhances efficacy of praziquantel.
Fallon PG; Doenhoff MJ
Parasite Immunol; 1995 May; 17(5):261-8. PubMed ID: 7675513
[TBL] [Abstract][Full Text] [Related]
7. ELISA detection of specific circulating antibodies against Schistosoma mansoni in mice after treatment with oxamniquine.
Coelho PM; Tavares CA
Braz J Med Biol Res; 1991; 24(5):485-93. PubMed ID: 1823263
[TBL] [Abstract][Full Text] [Related]
8. Schistosoma mansoni: chemotherapy of infections of different ages.
Sabah AA; Fletcher C; Webbe G; Doenhoff MJ
Exp Parasitol; 1986 Jun; 61(3):294-303. PubMed ID: 3086114
[TBL] [Abstract][Full Text] [Related]
9. Analysis of worm burdens in experimental schistosomiasis.
Fulford AJ; Yeang F
Parasitology; 1988 Oct; 97 ( Pt 2)():303-15. PubMed ID: 3143991
[TBL] [Abstract][Full Text] [Related]
10. Schistosoma mansoni: tegumental surface alterations following oxamniquine treatment of infected mice.
Amin AM; Mikhail EG
J Egypt Soc Parasitol; 1989 Dec; 19(2 Suppl):815-26. PubMed ID: 2507653
[TBL] [Abstract][Full Text] [Related]
11. Effects of praziquantel and oxamniquine on a Saudi Arabian strain of Schistosoma mansoni in mice.
Ghandour AM; Banaja AA; Shalaby IM
J Helminthol; 1990 Mar; 64(1):62-4. PubMed ID: 2110944
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of alternating therapy with oxamniquine and praziquantel to treat Schistosoma mansoni in children following failure of first treatment.
Katz N; Rocha RS; de Souza CP; Coura Filho P; Bruce JI; Coles GC; Kinoti GK
Am J Trop Med Hyg; 1991 May; 44(5):509-12. PubMed ID: 1905880
[TBL] [Abstract][Full Text] [Related]
13. Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates.
Fallon PG; Mubarak JS; Fookes RE; Niang M; Butterworth AE; Sturrock RF; Doenhoff MJ
Exp Parasitol; 1997 May; 86(1):29-36. PubMed ID: 9149238
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of Schistosomiasis mansoni with a combination oxamniquine and praziquantel. II. Experimental observations during the patent phase].
Campos R; Pinto PL; Amato Neto V; Moreira AA
Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(3):111-4. PubMed ID: 2515575
[TBL] [Abstract][Full Text] [Related]
15. Correlation between infection intensity, serum immunoglobulin profile, cellular immunity and the efficacy of treatment with praziquantel in murine schistosomiasis mansoni.
Nessim NG; Demerdash Z
Arzneimittelforschung; 2000 Feb; 50(2):173-7. PubMed ID: 10719623
[TBL] [Abstract][Full Text] [Related]
16. Oxamniquine, praziquantel and lovastatin association in the experimental Schistosomiasis mansoni.
Araújo N; Mattos AC; Sarvel AK; Coelho PM; Katz N
Mem Inst Oswaldo Cruz; 2008 Aug; 103(5):450-4. PubMed ID: 18797757
[TBL] [Abstract][Full Text] [Related]
17. Similar cellular responses after treatment with either praziquantel or oxamniquine in Schistosoma mansoni infection.
Mduluza T; Mutapi F; Ruwona T; Kaluka D; Midzi N; Ndhlovu PD
Malawi Med J; 2009 Dec; 21(4):176-82. PubMed ID: 21174933
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical Investigations of Treatment with Ro 13-3978, Praziquantel, Oxamniquine, and Mefloquine in Schistosoma mansoni-Infected Mice.
Panic G; Ruf MT; Keiser J
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971860
[TBL] [Abstract][Full Text] [Related]
19. Resistance to oxamniquine of a Schistosoma mansoni strain isolated from patient submitted to repeated treatments.
Coelho PM; Lima e Silva FC; Nogueira-Machado JA
Rev Inst Med Trop Sao Paulo; 1997; 39(2):101-6. PubMed ID: 9394523
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial.
Ferrari ML; Coelho PM; Antunes CM; Tavares CA; da Cunha AS
Bull World Health Organ; 2003; 81(3):190-6. PubMed ID: 12764515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
